Search

everythinglearnresearchcommunity

for

Search:↓

PCOS affects about 4% of women in the southeastern U.S. equally across Black and White populations.

The document concludes that hirsutism is the main sign for diagnosing hyperandrogenism, which requires a detailed patient history and physical exam.

The document concludes that accurate measurement of serum androgens is crucial for diagnosing hyperandrogenism.

Male hormones are important for hair and oil gland development and can cause conditions like excessive hair growth and acne.

Treatment of acromegaly can improve women's reproductive health issues caused by hormonal imbalances or tumors.

Female pattern hair loss is common, linked to polycystic ovarian syndrome, and treated with topical Minoxidil.

AMH helps estimate ovarian reserve but doesn't predict pregnancy chances; age is more important.

Daughters of women with PCOS generally experience normal puberty but may have more body hair and different body fat distribution.

The document says that understanding the causes of PCOS is important for treatment, especially in distinguishing the syndrome from just having cystic ovaries, and that losing weight is key for obese women with PCOS.

Birth control pills combined with bicalutamide are more effective at reducing excessive hair growth in women with PCOS than birth control pills alone.

Certain SHBG gene variants, like rs727428, are linked to higher testosterone levels in women with PCOS.

A combined drug and laser treatment improved hirsutism in a PCOS patient, also enhancing her heart health and requiring regular liver and kidney checks.

The document suggests that there might be an autoimmune link between polycystic ovary syndrome and Graves' disease.

Finasteride doesn't affect erections much, but may decrease libido in men.

Women with polycystic ovary syndrome have a higher risk of certain fractures.

Skin changes can indicate hormonal imbalances and help diagnose endocrine disorders.

Finasteride reduces prostate cancer risk but may increase high-grade cancer chances.

Medications for PCOS don't seem to raise heart disease risk.

Identifying nonclassic congenital adrenal hyperplasia and carriers of CYP21 mutations is challenging, and genetic counseling is recommended due to their prevalence.

Hyperandrogenism increases heart disease risk in premenopausal women, but this risk is linked to obesity in postmenopausal women.

The book is a valuable reference on androgenic disorders for professionals but not suitable for laypeople or medical students.

The guideline suggests using specific criteria to diagnose PCOS, recommends various treatments for its symptoms, and advises screening for related health issues.

Most women with excess male hormones have Polycystic Ovary Syndrome, and hormonal therapy can improve symptoms but may cause side effects.

Testosterone therapy increases bone density in older men with low testosterone levels.

Polycystic ovary syndrome costs the U.S. over $4 billion a year, mainly from treating related health issues.

The Endocrine Society advised against routine testosterone therapy for women, citing a need for more research on long-term safety and a clear definition of androgen deficiency.

Exposure to too much androgen before birth might cause polycystic ovary syndrome later in life.

Dutasteride and finasteride may reduce sperm count and volume but don't affect movement or shape; effects are reversible after stopping.

Metformin is effective for treating excessive hair growth in women with PCOS and may work better than the standard treatment in some ways.

Dihydrotestosterone gel improved well-being and sexual function in older men without negatively affecting prostate health.